|
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
****JavaScript based drop down DHTML menu generated by NavStudio. (OpenCube Inc. - http://www.opencube.com)****
|
|||||||||||||
![]() |
Executive in Residence | ||||||||||||
| W. Gene Winters, CPA | |||||||||||||
| Chief Financial Officer / Chief Strategy Officer | |||||||||||||
| Regency Hospital Company: | |||||||||||||
#2 Fastest Growing Company in Atlanta: |
Atlanta Business Chronicle, 2005 |
||||||||||||
#1 Best Company to Work For: |
Atlanta Business Chronicle, 2005 |
||||||||||||
Revenue Growth: Past Three Years: |
1814% (Projected 2005: $186MM) |
||||||||||||
EBITDA Growth: Past Three Years: |
5911% (Projected 2005: $42MM) |
||||||||||||
| Education: | |||||||||||||
| 1986 graduate of University of West Georgia | |||||||||||||
| Positions Held: | |||||||||||||
Chief Financial Officer |
Regency Hospital Company | 2001 - 2005 |
|||||||||||
| Division CFO | Mariner Post Acute Care: Hospital Division | 1995 - 2001 |
|||||||||||
| VP-Finance | Transitional Hospital Corporation | 1991 - 1995 |
|||||||||||
| Hospital CFO | Vencor Hospital - Houston | 1989 - 1991 |
|||||||||||
| Hospital CFO | Hospital Corporation of America (HCA) | 1986 - 1989 |
|||||||||||
His eighteen years of senior-level healthcare experience and financial expertise enable Regency to remain a recognized clinical & financial leader in the healthcare industry. At age 24, Gene served as the youngest hospital CFO in HCA’s history. By age 27, Gene was serving as CFO of Transitional Hospitals Corporation, a publicly-traded 23-hospital chain started under Gene’s leadership. After the chain was sold to Kindred Healthcare for $630MM, and selling a small subsequent 12-hospital chain to healthcare giant Mariner in 2000, Gene founded and invested in Regency. Other investors in Regency include such luminaries as Jack Welch, the former chairman of GE. In short, Regency has grown from a $13MM investment in 2001 to a company valued at $350MM in 2005. Current plans are to issue$125MM in high yield bonds in third quarter 2005 to continue growth over the next twelve months with an Initial Public Offering (IPO) scheduled for late 2006. |
|||||||||||||
| E-Mail | Phone: (678) 839-6467 | Fax: (678) 839-5040 | |||||||||||||